Ketty Peris

19PUBLICATIONS
135CO-AUTHORS
AllergyEpidemiological methodsMedical parasitologyMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Dec 10, 2024
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.

Stephan Weidinger, Anthony Bewley, H Chih-Ho Hong

|Jan 22, 2024
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors.

Eleonora De Luca, Pietro Sollena, Lucia Di Nardo

|Jun 13, 2023
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era.

Niccolò Gori, Elena Ippoliti, Ketty Peris

Pageof 4

Frequent Collaborators

8 joint publications

Andrea Chiricozzi

5 joint publications

Giacomo Caldarola

4 joint publications

Maria Concetta Fargnoli

4 joint publications

Luca Bianchi